Compare SYN-AKE-type Dipeptide Diaminobutyroyl Benzylamide Diacetate with Argireline-type Acetyl Hexapeptide-8. Written for cosmetic brands, formulators, distributors and professional B2B buyers.
The short answer
SYN-AKE and Argireline are different commercial peptide technologies. SYN-AKE is associated with Dipeptide Diaminobutyroyl Benzylamide Diacetate; Argireline is associated with Acetyl Hexapeptide-8. Neither trade name discloses the stock-solution concentration, carrier or preservative, so technical comparison must start with the exact grade.
Why they are grouped together
Both are commonly positioned for the appearance of dynamic or expression lines. Marketing sometimes compares them with injectable neuromodulators, but topical cosmetic products are not equivalent to medical injections. Use visible-appearance language supported by relevant testing and avoid claims about paralyzing muscles or replacing treatment.
Identity and concentration basis
Request full INCI composition, product code, peptide content, carrier system, pH guidance, storage and representative COA. A five-percent addition of one supplier solution cannot be compared with five percent of another unless active content and usable formula yield are normalized.
Evidence is not portable
A clinical study on a multi-ingredient serum containing both peptide families, acids or niacinamide supports that formula as tested. It does not isolate each peptide. Ingredient studies can guide selection but should not be presented as direct evidence for an untested finished serum.
Formula design
Choose a lightweight water-based base when targeting forehead or eye-area use, then control tack, migration and pilling. Verify compatibility with the exact supporting actives, preservative and package. Combining SYN-AKE and Argireline can create a broader story, but it also increases carrier load and claim complexity.
Which one should a brand choose?
Argireline has strong consumer name recognition; a SYN-AKE-type system may provide differentiation. Select based on authorized name use, evidence, active basis, cost-in-use, availability and formula behavior—not a claim that one universally outperforms the other.
Procurement questions
Ask whether the quote is for the branded grade or an INCI-equivalent material, which documents match the batch, how changes are notified and what sample represents commercial supply. Fix these answers in the purchase specification before artwork approval.
Selected research for further reading
These sources provide background and do not substitute for finished-product substantiation.
Need a product-specific specification?
Send the peptide, format, quantity, packaging and destination market. We will confirm composition, MOQ, documents and sample options.
Ask the B2B TeamPublished August 10, 2026. Educational B2B content; not medical advice.